643 articles in this topic
University of Zurich researchers tested psilocybin against placebo in 37 alcohol-dependent patients using rigorous double-blind methodology.
60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.
University researchers used psychedelic therapy and brain imaging to tackle cocaine addiction, revealing new neural pathways for recovery.
Large 6-year study tested dietary interventions including caloric restriction and omega-3s in 330 people with mild cognitive impairment.
Small pilot study tests multicomponent behavioral program to reduce cognitive decline risk in underserved rural populations.
18-month trial tested omega-3 supplementation in 774 older adults with low DHA/EPA levels and memory concerns to prevent cognitive decline.
French researchers followed 1,028 people with mild cognitive complaints to understand how dementia develops over time.
Nine-year study investigated whether solanezumab could slow memory decline in older adults with brain amyloid plaques.
New trial tests whether guanfacine can protect brain function in critically ill patients experiencing delirium and cognitive decline.
French study tests whether meditation practice can slow cognitive decline and improve mental health in seniors over age 65.
272-person trial tests needle-free ear pressure technique against chronic low back pain in seniors using smartphone tracking.
Researchers developed retinal imaging techniques to identify Alzheimer's biomarkers decades before clinical diagnosis.
